Novo Nordisk (NVO) plans to invest $4.1 billion in building out a manufacturing facility in Clayton, North Carolina for its GLP-1 weight-loss drugs Wegovy and Ozempic. This investment is happening a week after Eli Lilly (LLY) unveiled its new factory in Concord, North Carolina.

Yahoo Finance Health Reporter Anjalee Khemlani breaks down the details.

For more expert insight and the latest market action, click here to watch this full episode of Market Domination.

This post was written by Luke Carberry Mogan.